-
141
Innovative organ-on-a-chip platforms for exploring tumorigenesis and therapy in head and neck cancer
Published 2025-07-01Subjects: Get full text
Article -
142
-
143
Characteristics of immune-active and immune-silent phenotypes of early-stage cervical carcinoma as revealed by transcriptome sequencing
Published 2023-06-01Subjects: Get full text
Article -
144
Antitumor and immunomodulatory effects of oxygen therapy
Published 2023-11-01Subjects: Get full text
Article -
145
Exploring the effect of canine cancer-associated fibroblasts on T cell dynamics through the CXCL12/CXCR4 axis modulated by TGF-β1
Published 2025-08-01Subjects: Get full text
Article -
146
-
147
Tenascin‐C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
Published 2021-05-01Get full text
Article -
148
-
149
The tricky effects of TROP2 in lung cancer: from clinical practice back to fundamental investigations
Published 2025-08-01Get full text
Article -
150
-
151
-
152
The role of formin-like protein 1 in pancreatic cancer and its specific effects on immunity
Published 2025-08-01“…Moreover, formin-like protein 1 was linked to an inflamed tumor microenvironment and mediated epithelial–mesenchymal transition and programmed cell death 1 ligand 1 expression in pancreatic cancer. …”
Get full text
Article -
153
P16 | A 3D IN VITRO MODEL TO STUDY CAF PLASTICITY AND TUMOR-STROMA INTERACTIONS IN OVARIAN CANCER
Published 2025-08-01“… The tumor microenvironment (TME) plays a pivotal role in cancer progression and therapy resistance. …”
Get full text
Article -
154
Precision delivery of estrogen receptor antagonists using bioorthogonal chemistry-based intelligent nanocarriers to overcome cervical cancer drug resistance
Published 2025-10-01“…Nanocarriers designed for specific recognition of ERα and ERβ also enable modulation of the tumor microenvironment (TME) and exhibit synergistic potential when combined with immunotherapy to overcome drug resistance. …”
Get full text
Article -
155
Unleashing NK cells for cancer immunotherapy in lung cancer: biologic challenges and clinical advances
Published 2025-08-01“…Despite their promising potential for anti-tumor killing, NK cell function is often diminished within the tumor microenvironment. There are many factors that lead to decreased tumor-infiltrating NK cell killing, including immunoinhibitory factors from tumor cells and resident tissues, acquired immune tolerance, NK cell exhaustion, and the hypoxic state of the tumor microenvironment. …”
Get full text
Article -
156
Roles of the phagocytosis checkpoint in radiotherapy
Published 2025-08-01“…Phagocytosis checkpoints are regulated by a series of receptor-ligand binding molecules, respectively on the tumor cells and phagocytes, which mediate pro-phagocytosis or anti-phagocytosis signals, modulate tumor antigen presentation, and further determine the infiltration of tumor-specific cytotoxic T cells in the tumor microenvironment. Radiotherapy regulates the different phagocytosis checkpoints on the tumor cells and phagocytes to modulate phagocytic clearance and reshape the irradiated tumor microenvironment. …”
Get full text
Article -
157
Oxidative stress in cancer: from tumor and microenvironment remodeling to therapeutic frontiers
Published 2025-08-01“…Oxidative stress interacts with tumor cell growth regulation and tumor microenvironment remodeling, and has been a critical hallmark of cancer. …”
Get full text
Article -
158
Antibody-functionalized iron-based nanoplatform for ferroptosis-augmented targeted therapy of HER2-positive breast cancer
Published 2025-10-01“…In this study, we proposed an antibody-targeted nanoplatform responsive to the tumor microenvironment, aiming to induce ferroptosis in HER2+ breast cancer cells and thereby enhance the sensitivity to HER2-targeted drugs. …”
Get full text
Article -
159
Lymph node transcriptomic profiles suggest susceptibility to bleomycin-induced pulmonary toxicity in classic hodgkin lymphoma
Published 2025-08-01“…This study aimed to characterize the pre-therapeutic nodal tumor microenvironment in CHL patients with and without BPT development. …”
Get full text
Article -
160
PML localization in tumor associated macrophages as a prognostic marker in triple negative breast cancer
Published 2025-07-01“…This promotes a pro-inflammatory tumor microenvironment as seen in patients with adverse outcomes. …”
Get full text
Article